Skip to main navigation Skip to search Skip to main content

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

  • External organisation

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1030-1035
Number of pages6
JournalLeukemia & Lymphoma
Volume60
Issue number4
DOIs
Publication statusPublished - 2019

Research programs

  • EMC MM-02-41-03
  • EMC MM-03-32-04

Cite this